| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |